Cyclophosphamide, an antineoplastic drug, and vitamin E, the common antioxidant present in the diet, were administered in separate dosages and in combination to animals (rats) with fibrosarcoma, metastatic tumor of the connective tissues, induced. The anticancer drug (20mg/kg body weight) and the vitamin-E (400mg/kg body weight) was administered for a period of 28 days from the day of tumor transplantation.
SUMMARY:
Cyclophosphamide, an antineoplastic drug, and vitamin E, the common antioxidant present in the diet, were administered in separate dosages and in combination to animals (rats) with fibrosarcoma, metastatic tumor of the connective tissues, induced. The anticancer drug (20mg/kg body weight) and the vitamin-E (400mg/kg body weight) was administered for a period of 28 days from the day of tumor transplantation.
The individual and the combined effects of these two substances were investigated by checking the growth of the tumor. Tumor markers like lactate dehydrogenase (LDH), serum glutamate pyruvate transminase (SGPT), serum glutamate oxaloacetate transaminase (SGOT), acid phosphatase, and alkaline phosphatase were analyzed for the changes in their concentration in serum, liver, and kidney to assess the success of the therapy. The increased level of the enzymes in the fibrosarcoma-suffering rats (GPII) was reduced by cyclophosphamide treatment (GP III) and vitamin E administration (GP IV). Among the treated groups, the combination therapy (GP V) showed greater efficacy in the treatment of fibrosarcoma than did individual administration, as there was more reduction in the levels of enzymes in Group V than those in to Groups III and IV. The enzyme levels were brought to near the normal level.
INTRODUCTION
The 
MATERIALS AND METHODS
Adult albino male rats of the Wistar strain, weighing between 100-120 g, were used initially to induce fibrosarcoma by the method of Mohana and Purushothaman (7) . A 10% tumor cell suspension (0.5 ml) obtained from tumor locus was injected into the auxiliary region through a 16-gauge needle. The animals were maintained on standard commercial pelleted diet and water provided ad libitum.
Maintenance of cell line: Fibrosarcoma cell line (20-methyl cholanthreneinduced) maintained in 8-10 weeks old, Wistar male rats by regular s. c. passage of 106 cells, was used. A 1.0-m1 of a 10% cell suspension in physiological saline, containing the same number of cells as mentioned above, was injected into the axillary region through a 16-gauge sterile needle. The transplanted tumor becomes palpable after one week (7).
Experimental set up: Each group contained six animals.
Group I: These animals were kept as controls, and food and water given ad libitum.
Group II: Animals were transplanted with 20-methylcholanthrene-induced fibrosarcoma cell line, and given food and water ad libitum. They were orally given the drug vehicle, sunflower oil, alone for 28 days from the day of tumor transplantation.
Group III: These animals were transplanted with 20-methylcholanthrene induced fibrosarcoma cell line and given food and water were ad libitum. In addition, they were given orally 20 mg/kg body weight of cyclophosphamide dissolved in 6 ml of sunflower oil for 28 days from the day of tumor transplantation.
Group IV: These animals were transplanted with 20-methylcholanthrene induced fibrosarcoma cell line, and given food and water were ad libitum. These animals were given orally 400 mg/kg body weight of vitamin E dissolved in 4 ml of sunflower oil for 28 days from the day of tumor transplantation.
Group V: These animals were transplanted with 20-methylcholanthreneinduced fibrosarcoma cell line, and provided with food and water ad libitum.
In addition, they were given cyclophosphamide at 20 mg/kg body weight and vitamin E at 400 mg/kg body weight dissolved in sunflower oil (6 and 4 ml, respectively) separately through a stomach tube for 28 days from the day of tumor transplantation.
The animals were killed on the 29th day after the treatment with drugs for 28 days, by cervical dislocation, blood samples were collected and the tissues were dissected from the concerned organ of study, namely, the liver and kidney. Tissue protein and enzymes were estimated with a 10% tissue homogenate.
The homogenate was prepared in Tris-HC1 buffer. Extraction of proteins from the tissues was not carried out.
Biochemical parameters investigated:
Total protein was estimated by the method of Lowry et al (8) . The activity of lactate dehydrogenase (LDH) was measured by the method of King (9) . Alkaline phosphatase activity in serum was assayed by the method of Moog (10) as modified by King (9) . The procedure adopted for the assay of acid phosphatase was similar to that of alkaline phosphatase except that citrate buffer was used in the place of carbonate buffer and Mg ions were omitted from the incubation mixture.
The activity of serum glutamate oxaloacetate transminase (SCOT) and serum glutamate pyruvate transmaminase (SGPT) were assayed by the method of King (9). Table I shows the level of serum changes LDH, alkaline phosphatase, acid phosphatase, SGPT, and SGOT in the five groups of animals. Group I (control) animals were compared with Group II (induced) animals.
RESULTS
Group III (cyclophosphamide-treated) and IV (vitamin E-administered) animals were compared with Group II animals. The level of the tumor markers increased in Group II animals, while a significant decrease was observed in Group III, IV, and V animals. Among the latter groups, Group V animals had the maximum lowering of enzyme levels closer to control values. The content of Table II reflects the changes in the marker enzyme levels in liver homogenate of the five groups of animals. There is a marked increase in the level of enzyme in the induced animals compared with control animals. A reduction in the level of enzymes is observed in the three treated groups. Maximum lowering of the enzymes level is noted in the combination therapy-extended animals (Group V), the values being nearer to those in control animals than those in Group III and IV animals.
Table III depicts the changes in enzyme levels (the five tumor markers) in the control, induced and treated groups of animals in kidney homogenate. Increase in the level of marker enzymes in fibrosarcoma-induced animals as compared with normal animals decreased in Group III, IV and V animals. Among the Group III, IV, and V animals, the enzyme level in the Group V animals is lowered to a greater extent, approaching the level of control values, than the other two treated groups.
The restoration of the enzyme levels correlates with the antitumor efficacy of the drugs, vitamin E and cyclophosphamide, when we analyze these findings with other supportive observations like weight gain and histopathology (not presented here). Figure 1 shows the changes in body weight in control, fibrosarcoma-induced, and treated groups. Cachexia is characterized by generalized weakness, malnutrition and loss of body weight. The observed weight loss in fibrosarcoma-induced group may have been due to cachexia condition characteristic of cancer. Treatment with vitamin E, cyclophosphamide and combination therapy has prevented loss of body weight, leading to progressive weight gain in the treated groups. The study of Fig. 1 reveals that the major beneficial effect of combination therapy is the prevention of body weight loss. The greater decrease in the LDH level by the LDH has been recognized as a potential tumor marker for various types of cancers (13) . Increased activity of the enzyme is also seen in leukemia and in generalized carcinomatosis (14) . When the activity of LDH is taken for investigation, Combination therapy of cyclophosphamide and vitamin E achieved greater reduction in the acid phosphatase level in the serum, liver and kidney due to the above-mentioned activity of the two drugs.
In fibrosarcoma, the liver, lungs, and bones are the chiefly affected organs (22 
